Skip to main content
FishtownFish wrapped around the rod of AsclepiusMedicine
Preventive Primary Care
How Care Works
Virtual & Home Visits
Virtual care across 40 states + house calls in Philadelphia
Concierge vs. Direct Care
Zero visit copays, zero hidden fees, relationship model
Send Medical Records
Securely upload prior labs & notes before consultation
Common Questions (FAQ)
PCP scope, insurance, labs & cancellation policies
Services
Primary Care & Acute Visits
Same-day sick visits, refills & comprehensive PCP care
Chronic & Complex Care
POTS, MCAS, Long COVID, Lyme & fatigue workups
Hormones & Endocrine
TRT, thyroid, perimenopause, menopause & PCOS
Metabolic Health & Weight
Advanced lipid testing, GLP-1s & glucose monitoring
Longevity & Prevention
Medicine 3.0 baselines, VO2 max, DEXA & prevention
All Clinical Services
Comprehensive catalogue of 36+ clinical services
Membership
Membership Details
Unlimited direct access, continuous physician care
Care Packages
The Reset & Strategic Roadmap evaluations
Billing & Payment FAQ
HSA/FSA eligibility, transparent cancellation policy
About
Meet Dr. Ash
Your Physician
GER·O·SPAN
Our Clinical Framework
Clinical Library & Articles
Evidence-based health guides reviewed by Dr. Ash
What People Say
124 patient reviews across 6 platforms
Contact Dr. Ash
Reach out with questions or book an intro
Patient PortalStart Intake
The Architecture of Facial Aging
Fishtown Medicine•8 min read
4.96 (124)

The Architecture of Facial Aging

Ashvin Vijayakumar MD

Medically Reviewed

Ashvin Vijayakumar MD•Updated November 8, 2026
On This Page
  • Why does your face change shape across four layers (skin, fat, ligaments, and bone)?
  • How do BBL/IPL, 1927 nm Thulium (MOXI), Sofwave, and RF Microneedling (Morpheus8) compare?
  • Why can deep RF microneedling (Morpheus8) melt facial fat in lean faces, and why is hyaluronic acid filler a flawed "fix"?
  • Guidance from the Clinic
  • Why must a trained clinician examine every brown spot with a dermatoscope before BBL, IPL, or laser?
  • Common Questions
  • Why do I look tired even when I sleep eight hours?
  • Does Sofwave carry the same facial fat-loss risk as Morpheus8 or Ulthera?
  • How do I protect my facial volume if I am losing weight on a GLP-1 (semaglutide or tirzepatide)?
  • Deep Questions
  • How long does hyaluronic acid (HA) facial filler persist on MRI and surgical biopsy?
  • ✦Key Takeaways
  • Scientific References

Get a preventive doctor that knows you.

Consult Dr. Ash
TL;DR30-second take

Facial aging happens across four structural layers: the skin envelope, compartmentalized fat pads, retaining ligaments, and the bony skeleton. Because deep facial fat pads deflate with age, endurance training, or GLP-1 weight loss, choosing an in-office energy device requires matching heating depth to your anatomy. Surface light and laser devices like BBL/IPL (epidermis/papillary dermis) and 1927 nm thulium/MOXI (200-400 µm) target pigment and vessels without reaching fat, and Sofwave heats the mid-dermis at a fixed 1.5 mm depth. In contrast, deep radiofrequency (RF) microneedling (such as Morpheus8, 0.5-4 mm on the face) heats high-resistance fat preferentially - destroying adipocytes above 43-50 °C and accounting for an 11.6% fat-loss rate among FDA MAUDE adverse-event reports (Chou 2026; Oct 15, 2025 FDA safety communication). Every pigment treatment also requires pre-procedure dermoscopy by a trained clinician (Dinnes 2018; Hibler 2017).

TL;DR: A face changes shape across four stacked layers - skin, fat pads, retaining ligaments, and bone - which explains both why creams cannot refill a hollow cheek and why deep heat devices can backfire in a lean face.

  1. Protect the 4 structural layers upstream: Daily SPF 30+ and nightly tretinoin 0.025% to 0.05% rebuild dermal collagen (+80%). Low-glycemic meals, strength training, and timely perimenopause hormone care slow facial bone loss and fat-pad shrinkage.
  2. Match any energy device to its millimeter depth: BBL/IPL (epidermis and papillary dermis) and 1927 nm thulium (MOXI, 200 to 300 micrometers) treat brown spots and red veins with negligible fat risk; Sofwave heats the mid-dermis at a fixed 1.5 mm (+0.78 mm brow lift); deep RF microneedling (Morpheus8, 0.5 to 4 mm needles plus 1 mm heat spread) reaches subcutaneous fat, where fat cells undergo apoptosis at 43 to 45 °C and fat loss ranks among the top FDA MAUDE adverse events (prompting the October 15, 2025 FDA safety warning).
  3. Require trained dermoscopy before any BBL/IPL or pigment laser: Dermoscopy by a trained examiner lifts melanoma sensitivity from 76% to 92% (with 13.3-fold higher diagnostic odds when read by a dermatologist); never let a clinic laser an unchecked or questionable brown spot.

A 42-year-old marathon runner from Northern Liberties asked me during her checkup whether she should buy a three-session package of deep radiofrequency microneedling (Morpheus8) that a med-spa had pitched to "tighten" her hollow cheeks after a 20-pound weight loss. Because we do not sell cosmetic procedures, we looked together at the tissue physics and the October 15, 2025 FDA Safety Communication. Radiofrequency current heats high-resistance fat cells first (Franco et al., 2010; Boisnic et al., 2014), triggering fat cell apoptosis at 43 to 45 °C and making facial fat loss 11.6% of FDA MAUDE complication reports (ranking third overall in Chou, Myers & Avram 2026, and ranking first in the 2020-2025 MAUDE analysis by Camacho-Hubbard et al. 2026). In a runner whose cheek fat pads were already lean, firing 3 to 4 mm heated needles into her midface would have melted the cushioning she wanted to keep.

The Evidence-Based Facial Photoaging Playbook: Topicals, Devices, and Depth Safety

Why does your face change shape across four layers (skin, fat, ligaments, and bone)?

Serial CT and anatomic studies (Shaw 2011; Gierloff 2012; Mendelson 2012) show that facial aging is structural. While the outer skin loses collagen, the deep fat pads shrink, the eye sockets and jawbone recede, and ligaments tether the skin into grooves.

Thinking of the face as four stacked layers clarifies which tool solves which problem:

  1. Layer 1: The Skin Envelope (Epidermis & Dermis, ~1.0 to 2.0 mm thick): Sun damage (photoaging) and sugar-driven glycation (AGEs) break down collagen I and III (-56% in sun-damaged skin, Griffiths 1993). What works here: Daily SPF 30+, nightly tretinoin 0.025%-0.05%, vitamin C, and surface lasers (1927 nm thulium or BBL/IPL).
  2. Layer 2: The Fat Pads (Subcutaneous Plane, > 2.0 mm): The face is cushioned by separate superficial and deep fat pads (Gierloff et al., 2012). With age, high mileage running, chronic stress, or fast GLP-1 weight loss, the temple, under-eye (infraorbital), and mid-cheek (buccal/malar) pads shrink, while the lower jowl and smile-line pads slide down.
  3. Layer 3: Retaining Ligaments & Muscle: Strong ligaments anchor the skin to the skull. As fat deflates and bone recedes around them, those ligaments pull the skin into grooves (the tear trough under the eye and the pre-jowl groove along the jaw).
  4. Layer 4: The Bony Skeleton (Skull, Eye Socket, Midface, Jaw): Repeated CT scans (Shaw et al., 2011; Mendelson & Wong, 2012) prove that the bony eye socket widens, the midface (maxilla) loses forward support, and the jaw angle softens. In women, falling estrogen at menopause speeds up both facial bone loss and up to 30% skin collagen loss in the first 5 years (Thornton 2013).

How do BBL/IPL, 1927 nm Thulium (MOXI), Sofwave, and RF Microneedling (Morpheus8) compare?

The safety and results of any energy device depend on its heating depth. BBL/IPL and 1927 nm thulium stay in the top 0.2 to 0.3 mm for pigment and veins, Sofwave heats mid-dermal collagen at a fixed 1.5 mm, and deep RF microneedling (0.5 to 4 mm needles plus ~1 mm heat spread) reaches subcutaneous fat (Chou 2026; Camacho-Hubbard 2026).

FeatureBBL / IPL (Broadband / Intense Pulsed Light)1927 nm Thulium Laser (MOXI / Fraxel Dual 1927)Sofwave SUPERB (Parallel Ultrasound)RF Microneedling (Morpheus8 & Deep Insulated RF)
How It Works & TargetPulsed broadband light (~500-1200 nm) heats melanin (brown spots) and hemoglobin (red veins) (Weiss 2002).Non-ablative fractional laser heats water in shallow micro-columns (Oliveira Modena 2025).7 parallel ultrasound beams heat mid-dermal collagen to 60-70 °C with surface cooling (Wang 2021).Radiofrequency current between needles; heat tracks electrical resistance and concentrates in fat (Magro 2022).
Heating DepthEpidermis & papillary dermis~200 to 300 µm (0.2 to 0.3 mm)Fixed at 1.5 mm (mid-dermis)0.5 to 4.0 mm needles + ~1 mm heat zone (newer tips to 8 mm)
Main Clinical Evidence4-year follow-up (Weiss 2002): pigment, telangiectasia, and texture gains persisted in 79% to 83%, and a small pilot showed 57% of age-altered genes shifted toward a younger profile (Chang JID 2013). However, a blinded split-face RCT found zero improvement in wrinkles (Hedelund Arch Dermatol 2006).Significant dyspigmentation improvement at 1 and 3 months with ~50% MPASI melasma/pigment improvement in skin types III-V (Vanaman Wilson 2018), though pigment partly recurs by 3 months (Vingan 2023; only 7 RCTs in Oliveira Modena 2025).Multicenter trial (Wang 2021): 86% improved 1-3 wrinkle grades after 1 session and brow rose 0.78 mm with zero device-related AEs; in an Asian cohort, wrinkle responder rate faded from 38% to 15% by 9 months (Chung 2026; industry-funded).Across 41 studies (15 RCTs, Kumar 2026), improves acne scars and lower-face laxity; deliberately marketed for "subdermal adipose remodeling" (Magro 2022; Dayan 2019), shrinking submental fat by -19.6% (Kim 2023).
Main ComplicationsBurns, blisters, dark or white pigment marks, or masking an unbiopsied melanoma (Hibler 2017; Delker 2017).Mild redness and sandpaper-like micro-crusts for 3-5 days; partial pigment recurrence by month 3.Brief pain during pulse, transient redness or swelling; cleaner safety profile than deep 3.0-4.5 mm microfocused ultrasound (Chung 2026).Texture/scarring changes (25.0%), pigment changes (18.3%), and facial fat loss (11.6% in Chou 2026; ranked #1 in Camacho-Hubbard 2026; FDA Safety Warning Oct 15, 2025).
Subcutaneous Fat-Loss RiskNegligible (treats pigment and redness instead of wrinkles or fat).Negligible (stays at 0.2-0.3 mm).Not reported in MAUDE (stays within the dermis at 1.5 mm, unlike deeper Ulthera).Documented via MAUDE & case reports: Avoid deep (3-4 mm) passes over thin buccal, temporal, or submalar fat pads.

Why can deep RF microneedling (Morpheus8) melt facial fat in lean faces, and why is hyaluronic acid filler a flawed "fix"?

At a 3 to 4 mm needle depth plus ~1 mm of heat spread, RF microneedling reaches subcutaneous fat, where fat cells trap RF heat and die at 43 to 45 °C (Boisnic 2014; Somenek 2021; Benitez-Roig 2022). Fat loss ranked among the top complications in FDA MAUDE audits and triggered the October 15, 2025 FDA safety warning (Chou 2026; Camacho-Hubbard 2026).

While no prospective study has yet measured fat-loss risk by baseline fat thickness (current data come from passive MAUDE reports, biopsies, and case series), four facts explain why lean and athletic faces need extra care:

Longevity Medicine

A personalized longevity strategy starts with knowing your real baselines.

Start Your Longevity Assessment
  1. Deliberate Fat Melting Turns Into Hollowing in Lean Faces (Magro 2022; Dayan 2019; Benitez-Roig 2022): At 3 to 4 mm needle depth (plus ~1 mm of heat spread), the needle tip reaches the fat layer, where the device is sold for "subdermal adipose remodeling." Human biopsies show immediate fat-cell membrane bursting when the deep tip is used (Benitez-Roig 2022). Fat cells trap radiofrequency heat and die at 43 to 45 °C (Boisnic 2014; Somenek 2021; 20% survival after 1 minute at 50 °C, Franco 2010). What shrinks a heavy jowl creates unwanted hollowing over a thin cheek or temple fat pad.
  2. FDA MAUDE Reports & the October 15, 2025 FDA Safety Warning (Chou 2026; Camacho-Hubbard 2026; Tremaine 2015):
    • Across 224 FDA MAUDE adverse events from 2013 to 2025 (Chou, Myers & Avram, Dermatol Surg 2026), fat loss made up 11.6% of events, ranking third after texture change (25.0%) and pigment change (18.3%).
    • A second MAUDE review covering 2020 to 2025 (Camacho-Hubbard et al., Dermatol Surg 2026) ranked fat loss first, matching the October 15, 2025 FDA Safety Communication on RF microneedling injuries (and earlier RF divot reports in Tremaine & Avram 2015).
  3. Why Hyaluronic Acid (HA) Filler Carries Its Own Long Tail (Becker 2015; Chow 2022; Chang 2015): Patients who get post-RF hollowing are often offered hyaluronic acid (HA) filler as a quick fix, yet the data urge caution:
    • Prospective MRI (Becker et al., Dermatology 2015, n = 10): Over 12 months of MRI tracking, injected HA swelled to 331% of the injected volume at 1 month (from water binding) and showed zero volume loss at 12 months (formal MRI tracking past 12 months is lacking).
    • Multi-Year Biopsy Persistence & Migration (Chow 2022; Chang 2015): In 36 patients where HA filler was found during Mohs skin surgery (Chow et al., Dermatol Surg 2022), retained HA lasted up to 10.75 years, and stayed 3 years or longer in 36.8% of patients who knew their injection date. Around the eyes, retained HA has moved toward the surface and caused swelling up to 9 years after injection, confirmed on MRI and biopsy (Chang et al., 2015).
  4. Our Practical Protocol for Lean or Athletic Faces: In lean faces, choose shallow dermal options (such as 1.5 mm ultrasound or 0.5-1.5 mm microneedling), lower the energy over bone and thin skin as the maker advises (Magro 2022), skip deep passes over the cheek, temple, and under-cheek hollows, and take baseline photos.

Guidance from the Clinic

"Before you let anyone put heat or needles into your face, ask two questions: what millimeter depth does this device heat, and who checked my brown spots with a dermatoscope? BBL and 1927 nm lasers are pigment tools in the top third of a millimeter, Sofwave stays in the dermis at 1.5 millimeters, and deep 3-to-4-millimeter RF microneedling is built to melt fat - which is the last thing a lean runner's cheek needs." - Dr. Ash

Why must a trained clinician examine every brown spot with a dermatoscope before BBL, IPL, or laser?

Dermoscopy by a trained examiner lifts melanoma sensitivity from 76% to 92% at a fixed 80% specificity (Dinnes Cochrane 2018), with dermatologists showing 13.3-fold higher diagnostic odds than primary care clinicians (Chen JAMA Dermatol 2025). Pre-procedure screening stops cosmetic lasers from bleaching the surface of an undiagnosed lentigo maligna (Hibler 2017; Delker 2017).

Before booking BBL/IPL or a 1927 nm thulium (MOXI) session for facial brown spots:

  • Require a Clear Dermoscopic Diagnosis Before Any Light or Laser Pulse (ESLD 2019; IDS 2026; Chen 2025; Khalifian 2022): Both the European Society for Laser Dermatology (Passeron 2019) and the International Dermoscopy Society's 2026 lentigo maligna rules (Forsea 2026) state that blind lasering of brown spots must be avoided. While untrained dermoscopy users do no better than the naked eye (Kittler 2002), dermatologists had 13.3-fold higher odds of accurate melanoma diagnosis on dermoscopic images than primary care clinicians (Chen et al., JAMA Dermatol 2025), and 71% of skin laser lawsuits from 2012 to 2020 involved nonphysician operators (Khalifian et al., Dermatol Surg 2022). (Note: The USPSTF 2023 "I" statement applies only to people without concerning spots; a spot you want removed is a lesion of concern by definition, Mangione JAMA 2023.)
  • Know the Clinical Series & Dermoscopic Clues (Hibler 2017; Delker 2017; Zipser 2010; Kopera 1997): Pigment lasers can clear surface color while deeper melanoma cells survive with S-100 and HMB-45 markers intact (Kopera 1997; Lee 1998) or create pseudomelanoma pathology (Boer 2003; Hwang 2002). Across published series, 82% of 11 post-laser melanomas in Delker (2017) had no prior biopsy (4 reached Stage IV, >= 1 died), 67% of 12 in Zipser (2010) had no biopsy (3 died), and among 503 lentigo maligna patients at MSKCC (Hibler 2017), 7.4% had prior cosmetic treatment (78% unbiopsied) and 42% needed surgical margins >= 10 mm. Biopsy any spot showing asymmetric pigmented follicular openings, gray rhomboids, or slate-gray dots/globules (Schiffner 2000; Lallas 2016) before any laser session.
✦

Key Takeaways

  1. Treat the Right Layer: Use SPF 30+, tretinoin 0.025%-0.05%, 1927 nm thulium (200-300 µm), or BBL/IPL for Layer 1 (skin pigment and redness; note BBL/IPL does not improve wrinkles in blinded split-face RCTs, Hedelund 2006). Protect Layers 2 to 4 (fat pads, ligaments, bone) with strength training, blood sugar control, and timely menopause hormone care (Shaw 2011; Thornton 2013).
  2. Respect Fat-Cell Heat Limits (FDA Oct 15, 2025 Safety Warning): Fat cells undergo apoptosis at 43-45 °C (Boisnic 2014; Somenek 2021), and fat loss ranks among the top FDA MAUDE complications for RF microneedling (11.6% in Chou 2026; #1 in Camacho-Hubbard 2026). Skip deep (3-4 mm) RF microneedling over lean facial zones, and remember that HA fillers can persist up to 9-10.75 years on biopsy (Chow 2022; Chang 2015).
  3. Never Laser an Unchecked Brown Spot: Always get a dermoscopic exam from a trained examiner before BBL/IPL or pigment laser (92% sensitivity, Dinnes 2018; 13.3x higher dermatologist odds, Chen 2025; 71% of laser claims involve nonphysician operators, Khalifian 2022), and biopsy any equivocal lesion (Hibler 2017; IDS 2026).

Scientific References

  1. Facial Skeleton & Fat Compartment Aging: Shaw RB Jr, Katzel EB, Koltz PF, et al. Plast Reconstr Surg. 2011;127(1):374-383; Gierloff M, Stöhring C, Buder T, et al. Plast Reconstr Surg. 2012;129(1):263-273; Mendelson B, Wong CH. Aesthetic Plast Surg. 2012;36(4):753-760; and Thornton MJ. Dermatoendocrinol. 2013;5(2):264-270.
  2. RF Microneedling MAUDE Safety, Fat Loss, Adipocyte Physics & HA Filler Persistence: Chou M, Myers B, Avram M. "Analysis of US FDA Data on Radiofrequency Microneedling Device Complications." Dermatol Surg. 2026; Camacho-Hubbard I, Ibrahimi OA, Mariwalla K, Munavalli G. Dermatol Surg. 2026 (FDA Safety Communication, Oct 15, 2025); Tremaine AM, Avram MM. Lasers Surg Med. 2015;47(2):133-140; Benitez-Roig V, Trelles MA. Lasers Surg Med. 2022;54(5):688-697; Boisnic S, et al. Lasers Surg Med. 2014;46(2):94-103; Somenek MT, et al. Lasers Surg Med. 2021;53(3):337-343; Magro I, et al. Facial Plast Surg Aesthet Med. 2022; Becker M, et al. (HA MRI). Dermatology. 2015;230(4):367-374; Chow KV, et al. (Mohs HA Persistence). Dermatol Surg. 2022;48(4):436-441; and Chang JR, et al. Ophthalmic Plast Reconstr Surg. 2015;31(2):117-120.
  3. BBL/IPL, 1927 nm Thulium & Sofwave Trials: Weiss RA, Weiss MA, Beasley KL. Dermatol Surg. 2002;28(12):1115-1119; Chang AL, Bitter PH, Qu K, et al. J Invest Dermatol. 2013;133(2):394-402; Hedelund L, et al. Arch Dermatol. 2006;142(8):985-990; Vanaman Wilson MJ, et al. Dermatol Surg. 2018;44(6):779-787; Vingan NR, et al. Lasers Surg Med. 2023; Oliveira Modena DA, et al. Lasers Med Sci. 2025; Wang JV, Ferzli G, Jeon H, Geronemus RG, Kauvar A. Dermatol Surg. 2021;47(11):1492-1495; and Chung MMH, et al. Lasers Surg Med. 2026.
  4. Pre-Laser Dermoscopy, Operator Litigation & Lentigo Maligna: Dinnes J, et al. Cochrane Database Syst Rev. 2018;12:CD011902; Chen JY, Fernandez K, Fadadu RP, et al. JAMA Dermatol. 2025; Khalifian S, et al. Dermatol Surg. 2022;48(3):315-320; Kopera D, et al. Dermatology. 1997;194(4):338-343; Hibler BP, Connolly KL, Lee EH, Rossi AM, Nehal KS. Lasers Surg Med. 2017;49(9):819-826; Zipser MC, et al. Eur J Dermatol. 2010; Delker S, et al. J Dermatol. 2017; Passeron T, et al. (ESLD). JEADV. 2019; and Forsea AM, et al. (IDS). JEADV. 2026.
Medical Disclaimer: This resource provides clinical context for educational purposes. In the world of Precision Medicine, there is no "one size fits all" - the right plan must be matched to your unique history, physiology, and goals. Consult Dr. Ash to determine if this approach is right for you, particularly if you have chronic health conditions or are taking prescription medications.
Ashvin Vijayakumar MD (Dr. Ash)

Fishtown Medicine | Longevity

2418 E York St, Philadelphia, PA 19125·(267) 360-7927·hello@fishtownmedicine.com·HSA/FSA Eligible

Start Your Intake

Frequently Asked Questions

Common Questions

Under-eye "tiredness" is usually structural anatomy. As the deep under-eye fat pad shrinks and the bony eye socket widens (Shaw 2011; Gierloff 2012), the tear-trough ligament tethers the skin into a groove that casts a shadow. Eye creams cannot refill bone or fat, and retinoids near the lash line can irritate meibomian glands and raise eye pain (OR 6.37) and dryness (OR 2.69, Abbott IOVS 2026).
No device-related adverse events or fat-loss reports appeared in Sofwave clinical trials (Wang 2021; Chung 2026). Sofwave focuses its parallel ultrasound beams at a fixed 1.5 mm mid-dermal depth (raising the brow by 0.78 mm, though wrinkle response dropped from 38% to 15% by 9 months in Chung 2026), whereas deep ultrasound reaches 3.0 to 4.5 mm and Morpheus8 needles reach 0.5 to 4.0 mm on the face with ~1 mm of heat spread into fat (Chou 2026; Camacho-Hubbard 2026).
So-called "Ozempic face" is rapid shrinkage of the cheek and temple fat pads when weight drops fast. We prevent it by pacing weight loss steady and slow, eating 1.2 to 1.6 g/kg/day of protein, lifting weights 2 to 3 days/week (DEXA-tracked lean mass), and skipping deep heat devices (3-4 mm RF microneedling or deep ultrasound) over lean facial fat pads.

Deep-Dive Questions

While brochures often say hyaluronic acid (HA) fillers dissolve in 6 to 18 months, human MRI and surgical biopsies show a much longer tail. In the strongest prospective MRI study (Becker et al., *Dermatology* 2015, n = 10), injected HA swelled to 331% of its injected volume at 1 month and showed zero volume loss at 12 months. When Mohs surgeons checked incidental HA filler in 36 surgical patients (Chow et al., *Dermatol Surg* 2022), retained HA lasted up to 10.75 years (and 3 years or longer in 36.8% of patients who knew when they were injected), while eye-area series document HA migration and swelling up to 9 years post-injection (Chang et al., 2015). Because filler can linger and move for years, avoiding fat loss from deep RF microneedling is far safer than trying to refill a hollowed cheek later.

Ready when you are

Start your intake

The chat is our AI assistant, answering from our published guides. To talk it through with Dr. Ash himself, start with the intake.

Related Intelligence

Healthspan vs Lifespan: Why Living Longer Is Not Enough | Philadelphia

Healthspan vs Lifespan: Why Living Longer Is Not Enough | Philadelphia

Americans live to about 78 but spend the last 12 years sick and dependent. A Philadelphia primary care practice on why healthspan is the better metric.

Read Deep Dive
Precision Hormone Health for Men and Women: Beyond Normal

Precision Hormone Health for Men and Women: Beyond Normal

Hormone optimization for men (TRT, fertility) and women (BHRT, menopause). A Philadelphia primary care practice using a precision, longevity-focused approach.

Read Deep Dive
Menopause Specialist Philadelphia | Medicine 3.0 BHRT Strategy

Menopause Specialist Philadelphia | Medicine 3.0 BHRT Strategy

Move beyond symptom relief. A Philadelphia primary care practice using bio-identical hormone therapy and lifestyle care to protect brain, bone, and heart health.

Read Deep Dive

New patients

Talk it through with Dr. Ash.

Share the number or outcome you want to improve, and where you are starting from. Dr. Ash reads every intake personally.

HSA/FSA eligible
No initiation or cancellation fees
No copays
Tell Dr. Ash what’s going on →
FishtownFish wrapped around the rod of AsclepiusMedicine
Preventive Primary Care
2418 E York St, Philadelphia, PA 19125(267) 360-7927Primary care in PhiladelphiaHome visits in Greater PhiladelphiaPricing & MembershipGER·O·SPAN: our clinical frameworkDigital Health LiteracyClinical Evidence & Research

Serving Fishtown · Northern Liberties · East Kensington · Olde Richmond · Port Richmond · Old City · Callowhill · Poplar · Center City · Center City West · Art Museum · Bella Vista · Chestnut Hill · Fairmount · Fitler Square · Graduate Hospital · Logan Square · Manayunk · Queen Village · Rittenhouse · Roxborough · Society Hill · Southwark · Bryn Mawr, PA · Gladwyne, PA · Villanova, PA · Wayne, PA · Cherry Hill, NJ · Haddonfield, NJ · Medford, NJ · Moorestown, NJ · Voorhees, NJ

Explore by topic

Women’s Health
  • Perimenopause
  • Menopause 3.0
  • PCOS
  • Fertility
Men’s Health
  • Testosterone (TRT)
  • Sleep Apnea & Low T
  • Andropause
  • Low Libido
Metabolic
  • Medical Weight Loss
  • Ozempic vs Metformin
  • Fasting Protocols
  • Visceral Fat
Cardiovascular
  • apoB & Heart Health
  • apoB vs LDL
  • Lp(a) Cholesterol
  • ED & Heart Risk
Longevity + Performance
  • Healthspan vs Lifespan
  • Biological Age
  • VO2 Max
  • Zone 2 Training
Supplements
  • Magnesium
  • Creatine
  • Omega-3
  • Foundational Stack
  • Supplement Guides

Tools, pricing & comparisons

Tools & Guides

  • Normal vs. Optimal Lab Checker
  • Curated Clinical Packets
  • Playbooks & Protocols
  • Clinical Evidence & Research
Pricing & Labs
  • Pricing & Membership
  • 90% Wholesale Quest Labs
  • Cost-Plus Meds & Labs
  • HSA & Open Enrollment Calculator
Compare
  • Primary Care Models
  • Concierge vs. DPC
  • vs. Function Health
  • vs. One Medical
  • vs. Parsley Health
  • Urgent Care Alternative
Who We Care For
  • Primary Care in Philadelphia
  • Hospitality Leadership
  • Philadelphia Dads
  • Sports Club Medicine
Care in Philadelphia +
Direct Primary Care in Philadelphia, PAConcierge Medicine in Philadelphia, PAConcierge vs DPC in Philadelphia, PALongevity Medicine in Philadelphia, PAPreventive Care in Philadelphia, PAExecutive Physical in Philadelphia, PAAnnual Physical in Philadelphia, PAHealthspan Optimization in Philadelphia, PAFunctional Medicine in Philadelphia, PASame-Day Sick Visits in Philadelphia, PATestosterone Replacement Therapy in Philadelphia, PAPerimenopause Care in Philadelphia, PAMenopause Care in Philadelphia, PAThyroid Treatment in Philadelphia, PAPCOS Care in Philadelphia, PAGLP-1 Weight Loss in Philadelphia, PAMetabolic Health in Philadelphia, PAHormone Optimization in Philadelphia, PAAdvanced Lipid Testing in Philadelphia, PAVO2 Max Testing in Philadelphia, PADEXA Scan in Philadelphia, PACGM in Philadelphia, PALong COVID Care in Philadelphia, PAChronic Fatigue Treatment in Philadelphia, PAPOTS Treatment in Philadelphia, PAMCAS Treatment in Philadelphia, PALyme Disease Care in Philadelphia, PABrain Fog Treatment in Philadelphia, PASleep Disorders Treatment in Philadelphia, PAStrep Throat Treatment in Philadelphia, PAUTI Treatment in Philadelphia, PASinus Infection Treatment in Philadelphia, PASTI Testing in Philadelphia, PATravel Medicine in Philadelphia, PAPre-Op Clearance in Philadelphia, PASports Club Medicine in Philadelphia, PA

Made it this far? You’re already most of the way there. let’s get started → Dr. Ash reads every word personally.

Content is for educational purposes only and does not constitute medical advice.

TermsPrivacyScope of PracticeClinical IndependenceCare NetworkResearch & Monographs